rdf:type |
|
lifeskim:mentions |
umls-concept:C0003872,
umls-concept:C0008976,
umls-concept:C0024501,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0205177,
umls-concept:C0205263,
umls-concept:C0439234,
umls-concept:C0449258,
umls-concept:C0666743,
umls-concept:C1274040,
umls-concept:C1883709
|
pubmed:issue |
8
|
pubmed:dateCreated |
2007-8-28
|
pubmed:databankReference |
|
pubmed:abstractText |
To evaluate the effect of infliximab on progression of structural damage over 1 year in patients with active psoriatic arthritis (PsA) enrolled in the Induction and Maintenance Psoriatic Arthritis Clinical Trial 2.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0004-3591
|
pubmed:author |
pubmed-author:AntoniCC,
pubmed-author:BeutlerAA,
pubmed-author:BirbaraCC,
pubmed-author:DooleyL TLT,
pubmed-author:GeusensPP,
pubmed-author:GladmanD DDD,
pubmed-author:GuzzoCC,
pubmed-author:HalterDD,
pubmed-author:KavanaughAA,
pubmed-author:KruegerG GGG,
pubmed-author:ZhouBB,
pubmed-author:de VlamKK,
pubmed-author:van der HeijdeDD
|
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2698-707
|
pubmed:meshHeading |
pubmed-meshheading:17665424-Antibodies, Monoclonal,
pubmed-meshheading:17665424-Antirheumatic Agents,
pubmed-meshheading:17665424-Arthritis, Psoriatic,
pubmed-meshheading:17665424-Disease Progression,
pubmed-meshheading:17665424-Double-Blind Method,
pubmed-meshheading:17665424-Female,
pubmed-meshheading:17665424-Health Status,
pubmed-meshheading:17665424-Humans,
pubmed-meshheading:17665424-Joints,
pubmed-meshheading:17665424-Male,
pubmed-meshheading:17665424-Middle Aged,
pubmed-meshheading:17665424-Questionnaires,
pubmed-meshheading:17665424-Severity of Illness Index
|
pubmed:year |
2007
|
pubmed:articleTitle |
Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2.
|
pubmed:affiliation |
Leiden University Medical Center, Leiden, The Netherlands. d.vanderheijde@kpnplanet.nl
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|